Full Description
Immune Checkpoint Biology in Health and Disease, Volume 382 provides in-depth reviews on the latest progress concerning research on immune-checkpoint biology and its immunotherapeutic implications, especially in cancer. Topics connected to immune-checkpoint biology covered in this volume include Novel technologies for applying immune checkpoint blockers, Next-generation deconvolution of transcriptomic data to investigate the tumor microenvironment, Immune checkpoints targeting dendritic cells for antibody-based modulation in cancer, Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients, and much more.
Other sections cover Recent advancements in tumor microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis, Immune Modulation During Anti-Cancer Radio(immuno)therapy, and Preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy.
Contents
1. Novel technologies for applying immune checkpoint blockers
Robin Maximilian Awad, and Karine Breckpot
2. Next-generation deconvolution of transcriptomic data to investigate the tumor microenvironment
Lorenzo Merotto, Maria Zopoglou, Constantin Zackl, and Francesca Finotello
3. Immune checkpoints targeting dendritic cells for antibody-based modulation in cancer
Xin Lei, Yizhi Wang, Chayenne Broens, Jannie Borst, and Yanling Xiao
4. Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients
Pierre Van Mol, Elena Donders, Diether Lambrechts, and Els Wauters
5. Recent advancements in tumour microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis
Madhavi Dipak Andhari, Asier Antoranz, Frederik De Smet, and Francesca Maria Bosisio
6. Immune Modulation During Anti-Cancer Radio(immuno)therapy
Teresa Irianto, Udo S. Gaipl, and Michael Rückert
7. Preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy
Hui Pan, Peng Liu, Guido Kroemer, and Oliver Kepp
